Back To: Home : Featured Technology : Microbiome

CLICK HERE FOR WHAT'S NEW IN:
 

Molecular Devices to distribute ChanTestís cell lines
May 2011
SHARING OPTIONS:

SUNNYVALE, Calif.óMolecular Devices Inc. and ChanTest Corp. recently signed an agreement whereby Molecular Devices will distribute ChanTest's portfolio of more than 145 ion channel and 110 GPCR cell lines on a non-exclusive basis. Under the agreement, Molecular Devices will sell ChanTest's ion channel and GPCR cell lines, in addition to promoting ChanTest's cell optimization services. Mark Verheyden, president of Molecular Devices, says the distribution agreement allows Molecular Devices "to provide our customers a complete end-to-end solution for their ion channel and GPCR assays." Dr. Arthur Brown, founder of ChanTest, adds that "the ability to screen ion channels with automated electrophysiology is revolutionizing drug discovery." No financial details regarding the agreement were disclosed.

Back

PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.